AGENAS calls for submissions of medical devices for evaluation within National HTA Program

06

Mar 2023

National HTA Program for Medical Devices was published in September 2017. Despite the fact that it was possible to suggest technologies for evaluation, there was no information on the actual work being done or the outcomes/consequences of the assessments within this program.

On February 17, 2023, the National Agency for Regional Health Services (AGENAS) invited applicants to submit proposals for the evaluation of medical technologies within the National HTA Program for Medical Devices (PNHTADM).

Proposals can be made concerning both emerging technologies, i.e., technologies that do not yet have the CE marking, and those in the initial diffusion phase, commonly used or presumed obsolete devices, for the possible evaluation or re-evaluation of the appropriate use in the Italian National Health Service (NHS). Applicants can be regions, hospitals, NHS professionals, scientific societies, manufacturers and their associations, and citizens/patients and their associations.

The submissions can be made through the AGENAS webpage. The AGENAS’ HTA Operational Unit will analyze the submitted proposals to be submitted to the Steering Committee of Medical Devices within the Ministry of Health for the subsequent evaluation phase within the PNHTADM. See the full details here

This news is just one of about 300 market access news collected by our team in the subscription services "HTA Alerts" and "Reimbursement Alerts" every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news).

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks). First EU issues of both newsletters are available for download free-of-charge.

The latest related news

23

Mar 2023

In February 2023, the Scottish Health Technology Group, SHTG, released three MedTech-related assessments: selective internal radiation therapies (SIRT) for treating primary hepatocellular carcinoma, Feeling Good app, store-and-forward teledermatology for triage of primary care referrals.

Read more

16

Mar 2023

In January-February 2023, Health Technology Wales published sixteen Medtech-related Topic Exploration Reports (TER), including stereotactic radiosurgery, percutaneous implantation of pulmonary artery pressure sensors, ambulatory patch ECG devices, and others; however, Health Technology Wales will not proceed with full appraisals on these topics. No Guidance was released for Medtech in January-February 2023.

Read more

15

Mar 2023

In March 2023, a new ‘AI and Digital Regulations Service’ for developers and adopters of artificial intelligence (AI) and digital technologies was launched in England. Four organizations provide this multi-agency advisory service: NICE, Care Quality Commission, Medicines and Healthcare products Regulatory Agency, and Health Research Authority. The website is currently in public beta and focused on information for developers.

Read more

14

Mar 2023

The Ministry of Health has commissioned the Agency for Health Quality and Assessment of Catalonia (AQuAS) to develop, with the collaboration of the various agencies that make up the Spanish Network of Agencies for the Evaluation of Health Technologies and Benefits (RedETS), a specific methodological framework for the evaluation of digital health technologies that would allow a comprehensive assessment of this type of technology. The methodological framework is in the final phase of development.

Read more

13

Mar 2023

The HTA body of the Tuscany Regional Healthcare issues three types of documents: full HTA reports, rapid HTA reports, and motivational forms. With regional decree 3844 of March 02, 2023, Tuscany Regional Healthcare has published assessments of four medical devices in the cardiovascular and neurovascular treatment areas.

Read more